One of the main provisions of the 2012 Farm Bill is a “shallow-loss” program. This program is being portrayed as a safety net, but there are significant questions that must be examined before the program is enacted. At this event, Vince Smith and Barry Goodwin will discuss these questions and will release new research and analysis on the cost of shallow-loss programs.

ABSTRACT

Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety. According to the World Health Organization, some poor quality drugs are deliberately and fraudulently mislabeled with respect to identity or source while...

Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety.

For Barack Obama’s supporters on the left, to say his policy choices have been a disappointment would be an understatement. Explaining how this came about is Jack Goldsmith’s provocative new book.

The US food system is widely recognized as one of the safest in the world. Nevertheless, about one in every six American is sick every year from eating a contaminated food product. Food safety incidents often make the news and many perceive the US food system as vulnerable.

The Shadow Financial Regulatory Committee works to identify and analyze developing trends and ongoing events that promise to affect the efficiency and safe operation of sectors of the financial services industry; explore the spectrum of short- and long-term implications of emerging problems and policy changes; help develop private, regulatory and legislative responses to such problems that promote efficiency and safety and further the public interest; and to assess and respond to proposed and actual public policy initiatives with respect to the impact on the public interest.

Biologics are essential to oncology care. As patents for older biologics begin to expire, the United States is developing an abbreviated regulatory process for the approval of similar biologics, which raises important considerations for the safe and appropriate incorporation of biosimilars into clinical practice for patients with cancer.

Lawrence M. Mead, author of Expanding Work Programs for Poor Men (AEI Press, 2011), argues that poor fathers, like welfare mothers, need "both help and hassle."